Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.

Item
http://www.wikidata.org/entity/Q46602411
Vitamin K₂ therapy for postmenopausal osteoporosisPrior treatment with vitamin K(2) significantly improves the efficacy of risedronateBone and glucose metabolism: a two-way streetMenatetrenone for the treatment of osteoporosis.The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan.Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).Vitamin K: an old vitamin in a new perspective.Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up studyComment on "Bone Regulates Glucose Metabolism as an Endocrine Organ through Osteocalcin".Effect of alendronate on bone remodeling around implant in the rat.A four-season molecule: osteocalcin. Updates in its physiological roles.Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials.Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs.
P2860

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.

Item
http://www.wikidata.org/entity/Q46602411
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Response of serum carboxylated ...... in K2 in postmenopausal women.
@en
Response of serum carboxylated ...... in K2 in postmenopausal women.
@nl
type
label
Response of serum carboxylated ...... in K2 in postmenopausal women.
@en
Response of serum carboxylated ...... in K2 in postmenopausal women.
@nl
prefLabel
Response of serum carboxylated ...... in K2 in postmenopausal women.
@en
Response of serum carboxylated ...... in K2 in postmenopausal women.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Response of serum carboxylated ...... in K2 in postmenopausal women.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921